...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer

This good news indeed...although oncology trials generally crawl along at a snails pace.  In a couple years we may have something.

Share
New Message
Please login to post a reply